The IL-1 type 1 receptor is required for the development of LPS-induced airways disease
Brass, David M., PhD, Hollingsworth, John W., MD, Fessler, Michael B., MD, Savov, Jordan D., MD, PhD, Maxwell, Abby B., BS, Whitehead, Gregory S., MS, Burch, Lauranell H., PhD, Schwartz, David A., MD, MPH
Published in Journal of allergy and clinical immunology (01.07.2007)
Published in Journal of allergy and clinical immunology (01.07.2007)
Get full text
Journal Article